| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | NID2 DCHS2 FAT4 PCDHA9 PCDHGC5 CALML3 MCFD2 SPTA1 ANXA11 PCDHB4 DGKG PCDHA7 PCDHA5 PCDHA4 ACTN4 ADGRV1 CUBN LCP1 KCNIP2 ITPR2 FAT1 CELSR2 VCAN SLIT1 DCHS1 PCDHB1 PCDH7 | 7.10e-10 | 749 | 179 | 27 | GO:0005509 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | DLG5 TRIM2 MYO9A SPTA1 KIF16B SPIRE1 ACTN4 ADGRV1 LCP1 DCTN1 TUBGCP6 SPTBN5 RMDN3 PTPN4 ABLIM1 PTPRC EML5 BRCA2 KIF14 KIRREL1 FSCN1 PACRG PLK1 EPB41 | 4.87e-05 | 1099 | 179 | 24 | GO:0008092 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 FAT4 PCDHA9 PCDHGC5 EMB PCDHB4 PCDHA7 PCDHA5 PCDHA4 FAT1 CELSR2 DCHS1 PCDHB1 PCDH7 | 1.07e-09 | 187 | 180 | 14 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 FAT4 PCDHA9 PCDHGC5 EMB PCDHB4 PCDHA7 PCDHA5 PCDHA4 FAT1 CELSR2 DCHS1 PCDHB1 PCDH7 | 6.87e-07 | 313 | 180 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DPP4 DCHS2 DLG5 FAT4 PCDHA9 PCDHGC5 EMB GIMAP5 SPTA1 PCDHB4 PCDHA7 PCDHA5 PCDHA4 ADGRV1 NLGN3 FAT1 CD5 PTPRC CELSR2 ENTPD1 DCHS1 KIRREL1 TNR PCDHB1 PCDH7 IL7R | 2.43e-06 | 1077 | 180 | 26 | GO:0098609 |
| GeneOntologyBiologicalProcess | condensed mesenchymal cell proliferation | 2.60e-06 | 4 | 180 | 3 | GO:0072137 | |
| Domain | Cadherin_CS | DCHS2 FAT4 PCDHA9 PCDHGC5 PCDHB4 PCDHA7 PCDHA5 PCDHA4 FAT1 CELSR2 DCHS1 PCDHB1 PCDH7 | 3.63e-11 | 109 | 178 | 13 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 FAT4 PCDHA9 PCDHGC5 PCDHB4 PCDHA7 PCDHA5 PCDHA4 FAT1 CELSR2 DCHS1 PCDHB1 PCDH7 | 5.77e-11 | 113 | 178 | 13 | PS00232 |
| Domain | Cadherin | DCHS2 FAT4 PCDHA9 PCDHGC5 PCDHB4 PCDHA7 PCDHA5 PCDHA4 FAT1 CELSR2 DCHS1 PCDHB1 PCDH7 | 5.77e-11 | 113 | 178 | 13 | PF00028 |
| Domain | CADHERIN_2 | DCHS2 FAT4 PCDHA9 PCDHGC5 PCDHB4 PCDHA7 PCDHA5 PCDHA4 FAT1 CELSR2 DCHS1 PCDHB1 PCDH7 | 6.46e-11 | 114 | 178 | 13 | PS50268 |
| Domain | - | DCHS2 FAT4 PCDHA9 PCDHGC5 PCDHB4 PCDHA7 PCDHA5 PCDHA4 FAT1 CELSR2 DCHS1 PCDHB1 PCDH7 | 6.46e-11 | 114 | 178 | 13 | 2.60.40.60 |
| Domain | CA | DCHS2 FAT4 PCDHA9 PCDHGC5 PCDHB4 PCDHA7 PCDHA5 PCDHA4 FAT1 CELSR2 DCHS1 PCDHB1 PCDH7 | 7.23e-11 | 115 | 178 | 13 | SM00112 |
| Domain | Cadherin-like | DCHS2 FAT4 PCDHA9 PCDHGC5 PCDHB4 PCDHA7 PCDHA5 PCDHA4 FAT1 CELSR2 DCHS1 PCDHB1 PCDH7 | 8.07e-11 | 116 | 178 | 13 | IPR015919 |
| Domain | Cadherin | DCHS2 FAT4 PCDHA9 PCDHGC5 PCDHB4 PCDHA7 PCDHA5 PCDHA4 FAT1 CELSR2 DCHS1 PCDHB1 PCDH7 | 1.00e-10 | 118 | 178 | 13 | IPR002126 |
| Domain | Cadherin_2 | 1.85e-07 | 65 | 178 | 8 | PF08266 | |
| Domain | Cadherin_N | 1.85e-07 | 65 | 178 | 8 | IPR013164 | |
| Domain | Cadherin_tail | 2.53e-05 | 37 | 178 | 5 | PF15974 | |
| Domain | Cadherin_CBD | 2.53e-05 | 37 | 178 | 5 | IPR031904 | |
| Domain | LAM_G_DOMAIN | 2.89e-05 | 38 | 178 | 5 | PS50025 | |
| Domain | - | 3.46e-05 | 95 | 178 | 7 | 2.60.120.200 | |
| Domain | Laminin_G_2 | 3.73e-05 | 40 | 178 | 5 | PF02210 | |
| Domain | Cadherin_C | 4.75e-05 | 42 | 178 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 4.75e-05 | 42 | 178 | 5 | PF16492 | |
| Domain | LamG | 5.97e-05 | 44 | 178 | 5 | SM00282 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.00e-05 | 106 | 178 | 7 | IPR000152 | |
| Domain | EGF_CA | 1.69e-04 | 122 | 178 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.87e-04 | 124 | 178 | 7 | IPR001881 | |
| Domain | Laminin_G | 2.26e-04 | 58 | 178 | 5 | IPR001791 | |
| Domain | SPEC | 2.33e-04 | 32 | 178 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.33e-04 | 32 | 178 | 4 | IPR018159 | |
| Domain | rSAM/SH3_domain-containing | 2.69e-04 | 3 | 178 | 2 | IPR021090 | |
| Domain | SLY | 2.69e-04 | 3 | 178 | 2 | PF12485 | |
| Domain | EGF_Ca-bd_CS | 3.32e-04 | 97 | 178 | 6 | IPR018097 | |
| Domain | EGF_CA | 3.71e-04 | 99 | 178 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.91e-04 | 100 | 178 | 6 | PS00010 | |
| Domain | EF-hand-dom_pair | CALML3 MCFD2 SPTA1 DYTN DGKG ACTN4 LCP1 KCNIP2 TPCN1 PPP2R3C | 4.43e-04 | 287 | 178 | 10 | IPR011992 |
| Domain | PTPase_domain | 6.13e-04 | 41 | 178 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 6.13e-04 | 41 | 178 | 4 | PF00102 | |
| Domain | - | 9.18e-04 | 261 | 178 | 9 | 1.10.238.10 | |
| Domain | Spectrin | 1.31e-03 | 23 | 178 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.31e-03 | 23 | 178 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.31e-03 | 23 | 178 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.31e-03 | 23 | 178 | 3 | IPR001589 | |
| Domain | EF-hand_7 | 1.32e-03 | 85 | 178 | 5 | PF13499 | |
| Domain | EGF | 1.32e-03 | 126 | 178 | 6 | PF00008 | |
| Domain | EFhand_Ca_insen | 1.32e-03 | 6 | 178 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 1.32e-03 | 6 | 178 | 2 | IPR014837 | |
| Domain | EF_Hand_1_Ca_BS | 1.47e-03 | 175 | 178 | 7 | IPR018247 | |
| Domain | EF_HAND_2 | 1.71e-03 | 231 | 178 | 8 | PS50222 | |
| Domain | EF_hand_dom | 1.76e-03 | 232 | 178 | 8 | IPR002048 | |
| Pubmed | PCDHA9 PCDHGC5 PCDHB4 PCDHA7 PCDHA5 PCDHA4 CELSR2 PCDHB1 PCDH7 | 3.01e-10 | 77 | 183 | 9 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHA9 PCDHGC5 PCDHB4 PCDHA7 PCDHA5 PCDHA4 CELSR2 PCDHB1 PCDH7 | 4.27e-10 | 80 | 183 | 9 | 10716726 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 4.52e-09 | 72 | 183 | 8 | 10380929 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 5.65e-09 | 74 | 183 | 8 | 10817752 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 2.11e-08 | 57 | 183 | 7 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 2.39e-08 | 58 | 183 | 7 | 30377227 | |
| Pubmed | 2.56e-08 | 7 | 183 | 4 | 16059920 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 DLG5 AMPD2 DENND4A SASH1 MYO9A ZCCHC8 PPFIBP1 MPDZ SPIRE1 STIL RUSC2 ABLIM1 OSBPL3 KIF14 EIF3I PLK1 PCDH7 EPB41 PCM1 | 3.38e-08 | 861 | 183 | 20 | 36931259 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 7.36e-08 | 68 | 183 | 7 | 11230163 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CYP4V2 MYO9A INPP4A TMEM63B ARHGEF18 SPIRE1 ADGRV1 KCNIP2 PTPN18 CDC14B SNX29 NLGN3 PTPN4 ABLIM1 SUPT6H LPCAT3 SETBP1 ENTPD1 SCAF11 GREB1 PACRG SNX9 ZMYM4 EPB41 PCM1 CPNE7 | 8.42e-08 | 1489 | 183 | 26 | 28611215 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 DLG5 MBTD1 MYO9A RBBP8 ZCCHC8 TOPBP1 BRCA2 SUPT6H CD2BP2 KIF14 EIF3I PPP2R3C SNX9 ZMYM4 PCM1 | 1.04e-07 | 588 | 183 | 16 | 38580884 |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 2.38e-07 | 11 | 183 | 4 | 9655502 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 3.40e-07 | 28 | 183 | 5 | 15347688 | |
| Pubmed | DLG5 INTS7 ZCCHC8 PPFIBP1 SLC39A11 TOPBP1 PSMC1 MPDZ SPIRE1 FBXO11 URB2 RMDN3 ABLIM1 SUPT6H NOM1 IGHMBP2 MDC1 TMF1 KIF14 SCAF11 EIF3I EXOSC4 ZMYM4 EPB41 NOL8 | 3.52e-07 | 1497 | 183 | 25 | 31527615 | |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 3.55e-07 | 12 | 183 | 4 | 10612399 | |
| Pubmed | NOL4 ZFYVE16 RBBP8 ZCCHC8 INPP4A ZSCAN4 DCTN1 ZFHX4 BRCA2 TMF1 KIF14 ZMYM4 PCM1 | 3.84e-07 | 418 | 183 | 13 | 34709266 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DOCK4 DLG5 PPFIBP1 TUT7 CNTRL PSMC1 ACTN4 STIL LCP1 DCTN1 BRCA2 OSBPL3 KIF14 LTV1 PLK1 SNX9 EPB41 PCM1 | 6.86e-07 | 853 | 183 | 18 | 28718761 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DLG5 COL17A1 PPFIBP1 TUT7 PSMC1 ACTN4 EWSR1 USP16 WTAP ITPR2 ABLIM1 NOM1 CD2BP2 MDC1 TMPO KIF14 SCAF11 LTV1 EIF3I FSCN1 EXOSC4 NOL8 | 8.78e-07 | 1257 | 183 | 22 | 36526897 |
| Pubmed | AKAP6 DLG5 SASH1 KIF16B TOPBP1 SPIRE1 ADGRV1 TPCN1 TUBGCP6 SUPT6H SETBP1 MDC1 SCAF11 ZMYM4 | 9.33e-07 | 529 | 183 | 14 | 14621295 | |
| Pubmed | 9.68e-07 | 15 | 183 | 4 | 15640798 | ||
| Pubmed | AKAP6 AMPD2 MBTD1 ZBTB6 TUT7 CNTRL ARHGEF18 SPIRE1 FBXO11 ACTN4 CUBN DCTN1 NLGN3 PTPRC EML5 OSBPL3 VCAN ENTPD6 MKX QSOX2 | 1.29e-06 | 1084 | 183 | 20 | 11544199 | |
| Pubmed | AKAP6 ACAP1 PCDHA9 SASH1 PCDHA7 PCDHA5 CSMD2 PTPN4 CELSR2 BRCA2 TMPO | 1.54e-06 | 329 | 183 | 11 | 17474147 | |
| Pubmed | 1.67e-06 | 17 | 183 | 4 | 29911975 | ||
| Pubmed | 1.81e-06 | 209 | 183 | 9 | 36779422 | ||
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 2.14e-06 | 18 | 183 | 4 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 2.14e-06 | 18 | 183 | 4 | 10662547 | |
| Pubmed | ZCCHC8 TUT7 ANXA11 ACTN4 EWSR1 URB2 LCP1 SUPT6H MDC1 KIF14 SCAF11 EIF3I FSCN1 SNX9 PCM1 | 2.18e-06 | 653 | 183 | 15 | 22586326 | |
| Pubmed | 2.83e-06 | 6 | 183 | 3 | 19506035 | ||
| Pubmed | 2.83e-06 | 6 | 183 | 3 | 18426908 | ||
| Pubmed | PAPPA2 NID2 ZBTB6 SASH1 ZFYVE16 ZCCHC8 INPP4A ZSCAN4 EWSR1 DCTN1 PTPRC NOM1 CSPG4 EPAS1 | 3.38e-06 | 591 | 183 | 14 | 15231748 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | CDC14C PAPPA2 ABCA1 RNF19A ZSCAN4 KIF16B FBXO11 CDC14B LPCAT3 ENTPD1 TMPO | 3.96e-06 | 363 | 183 | 11 | 14691545 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | AMPD2 DENND4A PPFIBP1 SPIRE1 ACTN4 DCTN1 ABLIM1 TRAFD1 EML5 OSBPL3 LPCAT3 CD2BP2 LTV1 PACRG ATL2 PLK1 SNX9 MUC5AC EXOSC4 TCTN2 DNPEP | 7.00e-06 | 1321 | 183 | 21 | 27173435 |
| Pubmed | 7.26e-06 | 24 | 183 | 4 | 24698270 | ||
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 7.26e-06 | 24 | 183 | 4 | 26116661 | |
| Pubmed | CHAP is a newly identified Z-disc protein essential for heart and skeletal muscle function. | 7.87e-06 | 8 | 183 | 3 | 20215401 | |
| Pubmed | 8.04e-06 | 251 | 183 | 9 | 29778605 | ||
| Pubmed | 1.18e-05 | 9 | 183 | 3 | 26269593 | ||
| Pubmed | 1.18e-05 | 9 | 183 | 3 | 12154121 | ||
| Pubmed | FAT4 INTS7 ANXA11 CNTRL PSMC1 DCTN1 SETDB2 BRCA2 SUPT6H MDC1 DCHS1 KIF14 FSCN1 PLK1 ZMYM4 | 1.22e-05 | 754 | 183 | 15 | 35906200 | |
| Pubmed | 1.30e-05 | 146 | 183 | 7 | 21399614 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | TUT7 TOPBP1 FBXO11 URB2 WTAP NOM1 IGHMBP2 CD2BP2 TMPO SCAF11 LTV1 EIF3I PLK1 EXOSC4 NOL8 | 1.31e-05 | 759 | 183 | 15 | 35915203 |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 2.09e-05 | 157 | 183 | 7 | 30686591 | |
| Pubmed | 2.09e-05 | 31 | 183 | 4 | 19690177 | ||
| Pubmed | 2.29e-05 | 11 | 183 | 3 | 19584272 | ||
| Pubmed | 2.29e-05 | 11 | 183 | 3 | 24355925 | ||
| Pubmed | Dchs1-Fat4 regulation of osteogenic differentiation in mouse. | 2.29e-05 | 11 | 183 | 3 | 31358536 | |
| Pubmed | 2.29e-05 | 11 | 183 | 3 | 26114487 | ||
| Pubmed | 2.63e-05 | 66 | 183 | 5 | 12221128 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 17900358 | ||
| Pubmed | PLK1 targets CtIP to promote microhomology-mediated end joining. | 2.75e-05 | 2 | 183 | 2 | 30202980 | |
| Pubmed | Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. | 2.75e-05 | 2 | 183 | 2 | 15609081 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 19923902 | ||
| Pubmed | The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway. | 2.75e-05 | 2 | 183 | 2 | 21502810 | |
| Pubmed | A quantitative model of the switch cycle of an archaeal flagellar motor and its sensory control. | 2.75e-05 | 2 | 183 | 2 | 16192281 | |
| Pubmed | Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. | 2.75e-05 | 2 | 183 | 2 | 1680916 | |
| Pubmed | CD45 regulates migration, proliferation, and progression of double negative 1 thymocytes. | 2.75e-05 | 2 | 183 | 2 | 20624943 | |
| Pubmed | Birth and rapid subcellular adaptation of a hominoid-specific CDC14 protein. | 2.75e-05 | 2 | 183 | 2 | 18547142 | |
| Pubmed | Structural insights into recognition of MDC1 by TopBP1 in DNA replication checkpoint control. | 2.75e-05 | 2 | 183 | 2 | 23891287 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 27666967 | ||
| Pubmed | Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation. | 2.75e-05 | 2 | 183 | 2 | 14525771 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 14647413 | ||
| Pubmed | Giant cadherins Fat and Dachsous self-bend to organize properly spaced intercellular junctions. | 2.75e-05 | 2 | 183 | 2 | 25355906 | |
| Pubmed | An adenylyl cyclase-mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes. | 2.75e-05 | 2 | 183 | 2 | 19574217 | |
| Pubmed | Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. | 2.75e-05 | 2 | 183 | 2 | 20638239 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 18048348 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 15003449 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 16254212 | ||
| Pubmed | Structure of the planar cell polarity cadherins Fat4 and Dachsous1. | 2.75e-05 | 2 | 183 | 2 | 36797229 | |
| Pubmed | The fusion of early endosomes induces molecular-motor-driven tubule formation and fission. | 2.75e-05 | 2 | 183 | 2 | 22357949 | |
| Pubmed | Fascin Rigidity and L-plastin Flexibility Cooperate in Cancer Cell Invadopodia and Filopodia. | 2.75e-05 | 2 | 183 | 2 | 26945069 | |
| Pubmed | Mammalian cadherins DCHS1-FAT4 affect functional cerebral architecture. | 2.75e-05 | 2 | 183 | 2 | 25930014 | |
| Pubmed | Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1. | 2.75e-05 | 2 | 183 | 2 | 17005603 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 16625365 | ||
| Pubmed | Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. | 3.04e-05 | 12 | 183 | 3 | 16391231 | |
| Pubmed | RBBP8 ANXA11 TOPBP1 PSMC1 EWSR1 WTAP BRCA2 CD2BP2 MDC1 PLK1 DNPEP | 3.11e-05 | 453 | 183 | 11 | 29656893 | |
| Pubmed | 3.94e-05 | 13 | 183 | 3 | 18796539 | ||
| Pubmed | DPP4 ACAP1 ANXA11 CNTRL PSMC1 ENPP4 DCTN1 ITPR2 TUBGCP6 PTPRC OSBPL3 LPCAT3 IGHMBP2 ENTPD1 TMPO KIF14 ATL2 PCM1 | 4.91e-05 | 1168 | 183 | 18 | 19946888 | |
| Pubmed | 5.00e-05 | 14 | 183 | 3 | 30459452 | ||
| Pubmed | 5.21e-05 | 76 | 183 | 5 | 10574461 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MBTD1 INTS7 ZCCHC8 SPTA1 TOPBP1 FBXO11 EWSR1 WTAP ZIC5 SUPT6H OSBPL3 NOM1 CD2BP2 MDC1 TMPO SCAF11 EXOSC4 ZMYM4 NOL8 | 5.73e-05 | 1294 | 183 | 19 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RBBP8 ZCCHC8 USP16 WTAP TUBGCP6 ABLIM1 TRAFD1 PTPRC MDC1 TMPO SCAF11 PCDH7 ZMYM4 PCM1 | 6.66e-05 | 774 | 183 | 14 | 15302935 |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 7.03e-05 | 190 | 183 | 7 | 15161933 | |
| Pubmed | DLG5 COL17A1 PNLIP CALML3 ANXA11 CUBN KCNIP2 ABLIM1 ENTPD1 SLIT1 | 7.61e-05 | 415 | 183 | 10 | 16385451 | |
| Pubmed | 7.63e-05 | 16 | 183 | 3 | 8875997 | ||
| Pubmed | 7.63e-05 | 16 | 183 | 3 | 27760317 | ||
| Pubmed | 7.71e-05 | 133 | 183 | 6 | 15144186 | ||
| Pubmed | DENND4A ZFYVE16 PPFIBP1 KIF16B SNX29 ITPR2 RMDN3 LPCAT3 TMF1 TMPO PCDH7 | 8.07e-05 | 504 | 183 | 11 | 34432599 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 24448238 | ||
| Pubmed | Early-onset aging and defective DNA damage response in Cdc14b-deficient mice. | 8.23e-05 | 3 | 183 | 2 | 21262768 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 29861382 | ||
| Pubmed | Polθ is phosphorylated by PLK1 to repair double-strand breaks in mitosis. | 8.23e-05 | 3 | 183 | 2 | 37674080 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 25217958 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 36999590 | ||
| Pubmed | Cdc14b regulates mammalian RNA polymerase II and represses cell cycle transcription. | 8.23e-05 | 3 | 183 | 2 | 22355704 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 20585040 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 20719959 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 27590578 | ||
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 24349352 | ||
| Pubmed | Structural Basis of Diverse Homophilic Recognition by Clustered α- and β-Protocadherins. | 8.23e-05 | 3 | 183 | 2 | 27161523 | |
| Pubmed | 8.23e-05 | 3 | 183 | 2 | 10967549 | ||
| Interaction | LAG3 interactions | 3.31e-07 | 17 | 183 | 5 | int:LAG3 | |
| Interaction | XAGE1A interactions | 1.78e-06 | 41 | 183 | 6 | int:XAGE1A | |
| Interaction | LOC254896 interactions | 2.38e-06 | 43 | 183 | 6 | int:LOC254896 | |
| Interaction | C2CD4B interactions | 2.74e-06 | 44 | 183 | 6 | int:C2CD4B | |
| Interaction | YWHAE interactions | DLG5 AMPD2 DENND4A PNLIP SASH1 MYO9A MCFD2 PPFIBP1 PSMC1 SPIRE1 ACTN4 EWSR1 SAMSN1 DCTN1 WTAP RUSC2 RMDN3 PTPN4 ABLIM1 OSBPL3 TMPO KIF14 SCAF11 FGF12 EIF3I PCDH7 EPB41 PCM1 IL7R | 3.23e-06 | 1256 | 183 | 29 | int:YWHAE |
| Interaction | NXPH2 interactions | 1.13e-05 | 33 | 183 | 5 | int:NXPH2 | |
| Interaction | BICD1 interactions | DOCK4 PPFIBP1 ARHGEF18 STIL LCP1 DCTN1 TMF1 KIF14 PLK1 SNX9 PCM1 | 1.87e-05 | 250 | 183 | 11 | int:BICD1 |
| Interaction | DCANP1 interactions | 2.29e-05 | 19 | 183 | 4 | int:DCANP1 | |
| Interaction | YWHAZ interactions | DLG5 AMPD2 DENND4A SASH1 MYO9A PPFIBP1 SPTA1 ARHGEF18 SPIRE1 EWSR1 SAMSN1 DCTN1 WTAP RUSC2 RMDN3 PTPN4 ABLIM1 OSBPL3 AK5 MDC1 KIF14 SCAF11 PRR14L EIF3I ATL2 PCDH7 EPB41 PCM1 | 2.30e-05 | 1319 | 183 | 28 | int:YWHAZ |
| Interaction | CC2D1B interactions | 2.30e-05 | 38 | 183 | 5 | int:CC2D1B | |
| Interaction | YWHAG interactions | DOCK4 DLG5 AMPD2 DENND4A SASH1 MYO9A MCFD2 PPFIBP1 MPDZ SPIRE1 ACTN4 EWSR1 SAMSN1 RUSC2 RMDN3 PTPN4 ABLIM1 OSBPL3 KIF14 SCAF11 SMS EIF3I PLK1 PCDH7 EPB41 PCM1 IL7R | 2.35e-05 | 1248 | 183 | 27 | int:YWHAG |
| Interaction | PCDHA10 interactions | 4.23e-05 | 22 | 183 | 4 | int:PCDHA10 | |
| Interaction | UCN3 interactions | 5.09e-05 | 23 | 183 | 4 | int:UCN3 | |
| Interaction | BBS4 interactions | 6.58e-05 | 47 | 183 | 5 | int:BBS4 | |
| Interaction | YWHAQ interactions | DLG5 AMPD2 DENND4A SASH1 MYO9A MCFD2 PPFIBP1 SPTA1 SPIRE1 SAMSN1 WTAP RUSC2 RMDN3 PTPN4 ABLIM1 OSBPL3 TMPO KIF14 SMS EIF3I FSCN1 PCDH7 EPB41 PCM1 | 7.88e-05 | 1118 | 183 | 24 | int:YWHAQ |
| Cytoband | 5q31 | 4.34e-07 | 115 | 183 | 7 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 2.08e-04 | 298 | 183 | 7 | chr5q31 | |
| Cytoband | 4q31.3 | 2.58e-04 | 31 | 183 | 3 | 4q31.3 | |
| GeneFamily | Clustered protocadherins | 5.60e-07 | 64 | 138 | 7 | 20 | |
| GeneFamily | Cadherin related | 7.16e-06 | 17 | 138 | 4 | 24 | |
| GeneFamily | SAM and SH3 domain containing|Sterile alpha motif domain containing | 1.73e-04 | 3 | 138 | 2 | 731 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.18e-03 | 7 | 138 | 2 | 1113 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.57e-03 | 8 | 138 | 2 | 658 | |
| Coexpression | GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN | CYP4V2 ZBTB6 MYOM1 GIMAP5 SPTA1 TUT7 ATP8B2 FBXO9 MDC1 ENTPD1 EPB41 | 1.57e-07 | 200 | 181 | 11 | M7495 |
| Coexpression | RIEGE_DELTANP63_DIRECT_TARGETS_UP | 5.22e-07 | 138 | 181 | 9 | M41739 | |
| Coexpression | ERBB2_UP.V1_DN | 9.84e-06 | 197 | 181 | 9 | M2635 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.07e-05 | 199 | 181 | 9 | M5893 | |
| Coexpression | GSE30083_SP1_VS_SP2_THYMOCYTE_DN | 1.11e-05 | 200 | 181 | 9 | M5024 | |
| Coexpression | FINAK_BREAST_CANCER_SDPP_SIGNATURE | 2.92e-05 | 26 | 181 | 4 | M12461 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HMGL | DOCK4 DENND4A SPP1 GIMAP5 ACY3 ANXA11 SAMSN1 LCP1 PTPN18 ITPR2 PTPRC ENTPD1 KIF14 IL7R | 5.16e-05 | 577 | 181 | 14 | M39051 |
| Coexpression | GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN | 6.63e-05 | 195 | 181 | 8 | M7972 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP | 7.12e-05 | 197 | 181 | 8 | M4985 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 7.91e-05 | 200 | 181 | 8 | M7518 | |
| Coexpression | GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN | 7.91e-05 | 200 | 181 | 8 | M6372 | |
| Coexpression | GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP | 7.91e-05 | 200 | 181 | 8 | M6539 | |
| ToppCell | moderate-Lymphoid-Treg|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.55e-09 | 192 | 183 | 10 | e370ff5aaff7b7042ba9aaf93de43aa563b8b9f9 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 8.76e-09 | 195 | 183 | 10 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | COVID-19-Lymphoid-CD4_T_cells|COVID-19 / Condition, Lineage and Cell class | 1.06e-08 | 199 | 183 | 10 | 27ac7ad2f4c2028c355632cbb81f2b52439b85ad | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-08 | 161 | 183 | 9 | 140b3c7077947c541cff54f6754e2df968345f4d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-08 | 162 | 183 | 9 | 16f9fbcaa0093ffc5a2a5e32db6040e2cb519d47 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.90e-08 | 165 | 183 | 9 | d91fabc5b26c27577eea27be8a305fec5c004164 | |
| ToppCell | facs-Trachea-nan-18m-Lymphocytic|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-08 | 176 | 183 | 9 | 9dd862dcee6947a53189728f6b4cd40e7b67cb71 | |
| ToppCell | droplet-Bladder-nan-24m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-08 | 176 | 183 | 9 | 0089b50d607f4d2f18639fab0f3fc779227baa7a | |
| ToppCell | facs-Trachea-nan-18m-Lymphocytic-T_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-08 | 176 | 183 | 9 | d990e7af8120210100d13caa0465b27cf77a451a | |
| ToppCell | facs-Trachea-nan-18m-Lymphocytic-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-08 | 176 | 183 | 9 | 14c6c3fdb53f9dfc02b951bc955b90213110c089 | |
| ToppCell | facs-Heart-LA-18m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-08 | 178 | 183 | 9 | b4b4e021e86d1d523fa40695cb0a91021dee27d1 | |
| ToppCell | facs-Trachea-18m-Hematologic-lymphocytic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.14e-08 | 180 | 183 | 9 | c35cf2510183c09688453b12e721d264cf57caad | |
| ToppCell | facs-Trachea-18m-Hematologic-lymphocytic-T_cell-T_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.44e-08 | 181 | 183 | 9 | a23b2e12bc133166e3ed45ab7116f74afbca6eec | |
| ToppCell | facs-Trachea-18m-Hematologic-lymphocytic-T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.44e-08 | 181 | 183 | 9 | 7875fe64ec500a925245ab50cffd6890eabaea8c | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 6.44e-08 | 181 | 183 | 9 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.08e-08 | 183 | 183 | 9 | 377c2c6fcb2fd41396dd7a7a90e9d7ccafccf2f0 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.08e-08 | 183 | 183 | 9 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.08e-08 | 183 | 183 | 9 | f0a6f4f8563491c83fb991b9fb81e75fec7d1ace | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.08e-08 | 183 | 183 | 9 | 86c67f258fa25a818797df5d4df7f27b44cb5381 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-08 | 184 | 183 | 9 | 43313b0b4e4d4b18dd67ac0c525d7aa4db493f71 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.41e-08 | 184 | 183 | 9 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-08 | 184 | 183 | 9 | 8fc047977fad38fcd26eebcc279a688efd342ed8 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-08 | 184 | 183 | 9 | 290b8ef0bc4b7b99a2b35b96a756699d3f233b96 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.77e-08 | 185 | 183 | 9 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.77e-08 | 185 | 183 | 9 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | 15-Distal-Immune-Hematopoietic,_T_Cells|Distal / Age, Tissue, Lineage and Cell class | 7.77e-08 | 185 | 183 | 9 | 481e3d3b63f2e5b4783088523c3cf70a461aed27 | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 8.91e-08 | 188 | 183 | 9 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 9.33e-08 | 189 | 183 | 9 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 9.33e-08 | 189 | 183 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 9.76e-08 | 190 | 183 | 9 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.76e-08 | 190 | 183 | 9 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 9.76e-08 | 190 | 183 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.02e-07 | 191 | 183 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Control-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.07e-07 | 192 | 183 | 9 | 253cf4d2cf88ad8c45b73779336180840bef054b | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-Treg|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.07e-07 | 192 | 183 | 9 | 48d557071bad80edd3ec6e5ad8dcd97037da9553 | |
| ToppCell | Healthy_Control-Lymphoid-T-CCR7+_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.07e-07 | 192 | 183 | 9 | 5b197f65a87c315e4f50c77a7fdec3b342a863ad | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-07 | 193 | 183 | 9 | 544de0988510cc57744710d7cafe07aa27a0b99d | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-07 | 193 | 183 | 9 | 8f8d2006fb40a207c743cfd2e9a9f47c2bac1eea | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 1.27e-07 | 196 | 183 | 9 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-07 | 196 | 183 | 9 | 072e0e29be4639344ead4ea6ad521e3338f5f8af | |
| ToppCell | T_cells-GZMK+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.27e-07 | 196 | 183 | 9 | fa5c7fec9e0dcd7e62ff64704bfdf2a3437a43ba | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.33e-07 | 197 | 183 | 9 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-07 | 198 | 183 | 9 | f486747f2c96b403bdeee0dfe0cc2679ffeefa33 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.39e-07 | 198 | 183 | 9 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | distal-Hematologic-CD4+_Memory/Effector_T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.39e-07 | 198 | 183 | 9 | 7a89635f3567b4d2e6cd684c47be2e015d72a357 | |
| ToppCell | Severe_COVID-19-T/NK-CD4+_T_1|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.39e-07 | 198 | 183 | 9 | bc6b983fdb9547ef8a9e693bc15fced1b73e101f | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-07 | 198 | 183 | 9 | fc8099bce80d84b29bdcc87064d4d8375dddfa0f | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.39e-07 | 198 | 183 | 9 | 32ec322ed144c545014b191da5274d12feeaf96b | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.39e-07 | 198 | 183 | 9 | 1e281d8f0291e8cf814e9e5abd7f5860402a7c77 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_TRM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-07 | 198 | 183 | 9 | becd5ae642f8de541ac790fdca45cf6394f05cd4 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-07 | 198 | 183 | 9 | 74f190d8e337cff5ffb65d446cf784759e1c2a59 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.45e-07 | 199 | 183 | 9 | 4669b6be3b513d80b6f79bd10a1974fefdf58093 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-07 | 199 | 183 | 9 | b270d8274249103d3a1b4a4f8601c92fde007ed7 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-07 | 199 | 183 | 9 | 630acf00cc0ad50c9b783f4f71c42e11e5d68f8c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-07 | 199 | 183 | 9 | 5fc9bd5740e2e4d657c8c3dd26567db9a6da5af8 | |
| ToppCell | distal-2-Hematologic-CD4+_Memory/Effector_T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.45e-07 | 199 | 183 | 9 | 037623d279f4f5120be06bae230e69b8d5222af4 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-07 | 200 | 183 | 9 | 283c55076133de5ce195ccad997ffddc56ed32a2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.66e-07 | 155 | 183 | 8 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.69e-07 | 167 | 183 | 8 | 84551ee71f9d8d03d514711fc7ca4422c810140b | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.91e-07 | 168 | 183 | 8 | 84977db9d71e59208727885320cc18d80d064380 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-07 | 168 | 183 | 8 | 110c3c7c322e04a684a19c2b5434a502279fd000 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-07 | 168 | 183 | 8 | 735d30cfda1889740bdeb43e39330a52e8f4d599 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-07 | 170 | 183 | 8 | 26178277bf9c7f2f06b5c0b03d4b69d78e9580c4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-07 | 170 | 183 | 8 | c4f00c1acde1d3b521101e469101d10fd257653e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-07 | 170 | 183 | 8 | d3c1edaf0190d8927578043c372dba7477e75e14 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-07 | 174 | 183 | 8 | ecee7e012ccd7876fb9df8aa939f8eb05b0c2b13 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-07 | 174 | 183 | 8 | 693fc31bed0f560644e419fa70ef09f863425416 | |
| ToppCell | droplet-Bladder-Unstain-18m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-07 | 174 | 183 | 8 | 773329bb91b97578df138446cf62101dd0dad758 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-07 | 176 | 183 | 8 | acd05ca8952710feedbfe377b1330f3c2406d044 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-07 | 176 | 183 | 8 | 27c5ddd67de52101360ef7de8fcfa041066d97db | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-07 | 176 | 183 | 8 | 359a57aea89d8e6776eaefb0c3553a0dbcad5e58 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-07 | 176 | 183 | 8 | 77c6103639acd0f3d6a2171c5f37a8083b6c2cf0 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-mature_NK_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-07 | 177 | 183 | 8 | 93379bfd7484812bb45aa27c0324a75be9641685 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-07 | 178 | 183 | 8 | a9a8567d8fdc0fffd612fee16b5b29ef7b1c9307 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-07 | 178 | 183 | 8 | 5ecbea15efd304057aef826ec2f385997bfaf0c9 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.60e-07 | 178 | 183 | 8 | 28bb1e3e447261d0cb47e2b6343b17b2d74db525 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.93e-07 | 179 | 183 | 8 | ac0c257e63a5994282d8b350c1b517cc3fbee52a | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-07 | 180 | 183 | 8 | 86cdb1652f1736c38b501f07cf40ce99134cf597 | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-07 | 180 | 183 | 8 | 115ce9f048f933704a19759948dcc933245e63c4 | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-07 | 181 | 183 | 8 | 6bb4b19f7804319dd7cfa450c7d1c7b4e90f2450 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-07 | 181 | 183 | 8 | 1a82b38494ca609238e918c56f7938320b9d467d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.62e-07 | 181 | 183 | 8 | 13270b6ba6a9c8e5681c6f40000c643ce1d9344a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.62e-07 | 181 | 183 | 8 | 3e3c903b522dced6bec5dc447cc3f8bf9a9749e3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.99e-07 | 182 | 183 | 8 | 09d0793245d3d77ab5fc384c0b62637f736da50b | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-07 | 183 | 183 | 8 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.76e-07 | 184 | 183 | 8 | f9365feed31e48f3382588bab077f99c5a3f5b04 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.76e-07 | 184 | 183 | 8 | 3e9d75af578297950e469f23fb2d28393a2feef8 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-4|TCGA-Uvea / Sample_Type by Project: Shred V9 | 9.76e-07 | 184 | 183 | 8 | 9c56753e5e668be888662e4713cf4ce44e6c58fb | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.76e-07 | 184 | 183 | 8 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-06 | 185 | 183 | 8 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 185 | 183 | 8 | 212a8f6fb9eac0c6a89a20a9aa30d48c21abd375 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-CD4_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.02e-06 | 185 | 183 | 8 | 32f43ddc8a899827924834546db33928e353271b | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 186 | 183 | 8 | c5a27a128677aa04154eb78402d01fed149875de | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 186 | 183 | 8 | 629b19447a63412cf1468160a0fedb5dbe02fd72 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 186 | 183 | 8 | 8df32cde77bb0b3e2f37a9664e7b72ec99697395 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 186 | 183 | 8 | fac6e66c6512897f9d388dac7bc80a005d6d0293 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-06 | 187 | 183 | 8 | 42b20d7f0a4f9195b3d71dc0e089b5e0914ebcbb | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.10e-06 | 187 | 183 | 8 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.10e-06 | 187 | 183 | 8 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.15e-06 | 188 | 183 | 8 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| Drug | Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A | MBTD1 ABCA1 PCDHA9 TRIM2 ANXA11 BAG4 RUSC2 LPCAT3 PRR14L GREB1 FSCN1 PCM1 | 5.56e-08 | 196 | 180 | 12 | 3534_DN |
| Drug | semustine; Down 200; 100uM; MCF7; HT_HG-U133A | PAPPA2 PCDHA9 CALML3 CNTRL BAG4 PCDHA5 TMPO TTC39A ATL2 MUC5AC PCDH7 | 5.62e-07 | 199 | 180 | 11 | 7487_DN |
| Drug | Terfenadine [50679-08-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 3.03e-06 | 191 | 180 | 10 | 2227_DN | |
| Drug | Biotin [58-85-5]; Down 200; 16.4uM; PC3; HT_HG-U133A | CALML3 BAG4 FBXO11 ENPP4 PTPN18 CDC14B VCAN ENTPD1 PCDH7 RAI2 | 3.65e-06 | 195 | 180 | 10 | 6689_DN |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; PC3; HT_HG-U133A | 4.18e-06 | 198 | 180 | 10 | 4654_DN | |
| Drug | 5194442; Down 200; 20uM; MCF7; HT_HG-U133A | 4.18e-06 | 198 | 180 | 10 | 6599_DN | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | DENND4A TRIM2 ANXA11 MPDZ ENPP4 CDC14B TPCN1 TRAFD1 FSCN1 ATL2 | 4.37e-06 | 199 | 180 | 10 | 7471_DN |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; PC3; HT_HG-U133A | DPP4 CALML3 INPP4A PCDHA5 PTPN18 ATP8B2 TPCN1 TCTN2 CPNE7 DNPEP | 4.57e-06 | 200 | 180 | 10 | 4076_DN |
| Drug | Azacitidine | PCDHA9 PCDHB4 PCDHA7 PCDHA5 PCDHA4 PTHLH APOBEC3F NLGN3 PTPRC AK5 NOM1 MDC1 ENTPD1 TMPO | 5.92e-06 | 415 | 180 | 14 | ctd:D001374 |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.72e-05 | 185 | 180 | 9 | 4755_DN | |
| Drug | 2,4,4'-trichlorobiphenyl | NOL4 MBTD1 PNLIP INTS7 INPP4A SPTA1 CNTRL TOPBP1 LILRA6 PROCA1 DGKG URB2 STIL PGC SNX29 PTPN4 ABLIM1 CELSR2 ZFHX4 BRCA2 SETBP1 RP1L1 KIRREL1 FGF12 TTC39A GREB1 PLK1 | 1.78e-05 | 1411 | 180 | 27 | ctd:C081766 |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.41e-05 | 193 | 180 | 9 | 3258_DN | |
| Drug | 5707885; Up 200; 50uM; MCF7; HT_HG-U133A | 2.51e-05 | 194 | 180 | 9 | 6385_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.51e-05 | 194 | 180 | 9 | 3606_DN | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 2.51e-05 | 194 | 180 | 9 | 3539_DN | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | NOL4 MBTD1 PNLIP INTS7 INPP4A SPTA1 CNTRL TOPBP1 LILRA6 PROCA1 DGKG URB2 STIL PGC SNX29 PTPN4 ABLIM1 CELSR2 ZFHX4 BRCA2 SETBP1 RP1L1 KIRREL1 FGF12 TTC39A GREB1 PLK1 | 2.58e-05 | 1441 | 180 | 27 | ctd:C009828 |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.61e-05 | 195 | 180 | 9 | 5004_DN | |
| Drug | Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.61e-05 | 195 | 180 | 9 | 3254_DN | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.61e-05 | 195 | 180 | 9 | 3530_DN | |
| Drug | Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.61e-05 | 195 | 180 | 9 | 7426_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.72e-05 | 196 | 180 | 9 | 1531_DN | |
| Drug | Betazole hydrochloride; Down 200; 27uM; PC3; HT_HG-U133A | 2.72e-05 | 196 | 180 | 9 | 6344_DN | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; HL60; HT_HG-U133A | 2.72e-05 | 196 | 180 | 9 | 2974_DN | |
| Drug | Atracurium besylate [64228-81-5]; Up 200; 3.2uM; PC3; HT_HG-U133A | 2.83e-05 | 197 | 180 | 9 | 1824_UP | |
| Drug | Propantheline bromide [50-34-0]; Down 200; 9uM; PC3; HT_HG-U133A | 2.83e-05 | 197 | 180 | 9 | 4214_DN | |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.94e-05 | 198 | 180 | 9 | 3246_DN | |
| Drug | Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; PC3; HT_HG-U133A | 3.19e-05 | 200 | 180 | 9 | 5842_DN | |
| Drug | B-Ni | 4.20e-05 | 25 | 180 | 4 | CID000446236 | |
| Drug | Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; HL60; HG-U133A | 5.68e-05 | 167 | 180 | 8 | 1607_UP | |
| Drug | sr17 | 6.22e-05 | 2 | 180 | 2 | CID000150317 | |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.25e-04 | 187 | 180 | 8 | 3244_DN | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.35e-04 | 189 | 180 | 8 | 3788_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; PC3; HT_HG-U133A | 1.50e-04 | 192 | 180 | 8 | 6664_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.50e-04 | 192 | 180 | 8 | 4743_DN | |
| Drug | Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; PC3; HT_HG-U133A | 1.56e-04 | 193 | 180 | 8 | 3672_DN | |
| Drug | Alprostadil [745-65-3]; Up 200; 11.2uM; HL60; HT_HG-U133A | 1.59e-04 | 145 | 180 | 7 | 2938_UP | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.67e-04 | 195 | 180 | 8 | 6035_DN | |
| Drug | semustine; Down 200; 100uM; MCF7; HT_HG-U133A | 1.67e-04 | 195 | 180 | 8 | 7540_DN | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.67e-04 | 195 | 180 | 8 | 4814_UP | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A | 1.67e-04 | 195 | 180 | 8 | 4533_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.67e-04 | 195 | 180 | 8 | 6718_UP | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 3536_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 1684_UP | |
| Drug | sulfasalazine; Down 200; 100uM; MCF7; HG-U133A | 1.73e-04 | 196 | 180 | 8 | 204_DN | |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 7429_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 6028_DN | |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; PC3; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 5069_DN | |
| Drug | Prenylamine lactate [69-43-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 5489_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 6029_DN | |
| Drug | Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 6905_UP | |
| Drug | F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 180 | 8 | 6396_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.79e-04 | 197 | 180 | 8 | 6796_UP | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.79e-04 | 197 | 180 | 8 | 3629_DN | |
| Drug | Etodolac [41340-25-4]; Up 200; 14uM; PC3; HT_HG-U133A | 1.79e-04 | 197 | 180 | 8 | 2091_UP | |
| Drug | Tropicamide [1508-75-4]; Down 200; 14uM; PC3; HT_HG-U133A | 1.79e-04 | 197 | 180 | 8 | 3722_DN | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; HL60; HT_HG-U133A | 1.79e-04 | 197 | 180 | 8 | 1842_UP | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; PC3; HT_HG-U133A | 1.79e-04 | 197 | 180 | 8 | 7293_DN | |
| Drug | Altretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A | 1.85e-04 | 198 | 180 | 8 | 5688_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 1.85e-04 | 198 | 180 | 8 | 4301_UP | |
| Drug | prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 1.85e-04 | 198 | 180 | 8 | 6590_UP | |
| Drug | troglitazone; Down 200; 10uM; SKMEL5; HG-U133A | 1.85e-04 | 198 | 180 | 8 | 504_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.85e-04 | 198 | 180 | 8 | 5334_UP | |
| Drug | Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; MCF7; HT_HG-U133A | 1.85e-04 | 198 | 180 | 8 | 5487_DN | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; HL60; HT_HG-U133A | 1.85e-04 | 198 | 180 | 8 | 3017_UP | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 1.85e-04 | 198 | 180 | 8 | 1798_UP | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; PC3; HT_HG-U133A | 1.85e-04 | 198 | 180 | 8 | 4070_DN | |
| Drug | Azathioprine [446-86-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.85e-04 | 198 | 180 | 8 | 5262_DN | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.85e-04 | 198 | 180 | 8 | 1464_UP | |
| Drug | Tadjakonine [11087-94-8]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.92e-04 | 199 | 180 | 8 | 2165_DN | |
| Drug | Isopropamide iodide [71-81-8]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.92e-04 | 199 | 180 | 8 | 7133_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; PC3; HT_HG-U133A | 1.92e-04 | 199 | 180 | 8 | 4438_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.92e-04 | 199 | 180 | 8 | 2231_DN | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 1.92e-04 | 199 | 180 | 8 | 5426_UP | |
| Drug | Iopanoic acid [96-83-3]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.92e-04 | 199 | 180 | 8 | 5448_UP | |
| Drug | Imipramine hydrochloride [113-52-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 1.98e-04 | 200 | 180 | 8 | 1685_UP | |
| Drug | Artemisinin [63968-64-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.98e-04 | 200 | 180 | 8 | 7007_UP | |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.98e-04 | 200 | 180 | 8 | 3276_DN | |
| Drug | Epiandrosterone [481-29-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.98e-04 | 200 | 180 | 8 | 5687_DN | |
| Drug | 1-oleoyl-2-acetylglycerol | 2.06e-04 | 15 | 180 | 3 | ctd:C038237 | |
| Disease | visceral adipose tissue measurement, body mass index | 1.45e-05 | 87 | 177 | 6 | EFO_0004340, EFO_0004765 | |
| Disease | 1,5 anhydroglucitol measurement | 2.64e-05 | 29 | 177 | 4 | EFO_0008009 | |
| Disease | neutrophil count | PAPPA2 NDST1 ACAP1 DENND4A PCDHA9 ZNF391 EMB RBBP8 DGKG PCDHA7 PCDHA5 PCDHA4 PGC ITPR2 AZIN1 TRAFD1 PTPRC RP1L1 KIRREL1 PPP2R3C TNR ZMYM4 | 3.00e-05 | 1382 | 177 | 22 | EFO_0004833 |
| Disease | post-traumatic stress disorder | 3.18e-05 | 202 | 177 | 8 | EFO_0001358 | |
| Disease | Van Maldergem Wetzburger Verloes syndrome | 3.58e-05 | 2 | 177 | 2 | C1832390 | |
| Disease | Van Maldergem syndrome | 3.58e-05 | 2 | 177 | 2 | cv:C1832390 | |
| Disease | Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive | 3.58e-05 | 2 | 177 | 2 | C1837028 | |
| Disease | Periventricular gray matter heterotopia | 3.58e-05 | 2 | 177 | 2 | C1849173 | |
| Disease | newborn respiratory distress syndrome (implicated_via_orthology) | 1.07e-04 | 3 | 177 | 2 | DOID:12716 (implicated_via_orthology) | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 1.07e-04 | 3 | 177 | 2 | C1842563 | |
| Disease | Profound Mental Retardation | 1.99e-04 | 139 | 177 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.99e-04 | 139 | 177 | 6 | C0025363 | |
| Disease | Mental deficiency | 1.99e-04 | 139 | 177 | 6 | C0917816 | |
| Disease | PR interval | AKAP6 DOCK4 EMB FBXO11 PCDHA4 ADCY5 FAT1 HFM1 FGF12 TTC39A EPAS1 | 2.13e-04 | 495 | 177 | 11 | EFO_0004462 |
| Disease | Hereditary elliptocytosis | 2.13e-04 | 4 | 177 | 2 | cv:C0013902 | |
| Disease | carcinoid tumor | 2.13e-04 | 4 | 177 | 2 | EFO_0004243 | |
| Disease | Abnormality of refraction | AKAP6 PCDHA9 EMB PCDHA7 PCDHA5 PCDHA4 DCTN1 ADCY5 ITPR2 ENTPD6 KIRREL1 PCDH7 QSOX2 | 2.27e-04 | 673 | 177 | 13 | HP_0000539 |
| Disease | Primary microcephaly | 3.00e-04 | 22 | 177 | 3 | C0431350 | |
| Disease | uric acid measurement | FAT4 ABCA1 INTS7 MYO9A ADGRV1 CUBN DCAF12L2 TRAFD1 SETBP1 HFM1 QSOX2 EPAS1 | 3.35e-04 | 610 | 177 | 12 | EFO_0004761 |
| Disease | Elliptocytosis, Hereditary | 5.28e-04 | 6 | 177 | 2 | C0013902 | |
| Disease | age at assessment, lateral ventricle volume change measurement | 5.58e-04 | 27 | 177 | 3 | EFO_0008007, EFO_0021502 | |
| Disease | reticulocyte measurement | ABCA1 DENND4A TRIM2 ZCCHC8 SPTA1 TUT7 ACTN4 GCSAML LCP1 PTHLH AZIN1 FAT1 PTPRC AK5 SETBP1 EPB41 | 6.37e-04 | 1053 | 177 | 16 | EFO_0010700 |
| Disease | platelet component distribution width | SPTA1 KIF16B EWSR1 GCSAML ENPP4 CUBN LCP1 ADCY5 PTPRC ENTPD1 SNX9 EPAS1 EPB41 | 6.70e-04 | 755 | 177 | 13 | EFO_0007984 |
| Disease | Osteolysis | 7.37e-04 | 7 | 177 | 2 | C4721411 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 8.43e-04 | 31 | 177 | 3 | EFO_0022249 | |
| Disease | common bile duct neoplasm (is_marker_for) | 9.78e-04 | 8 | 177 | 2 | DOID:4608 (is_marker_for) | |
| Disease | asthma, response to diisocyanate | 1.05e-03 | 261 | 177 | 7 | EFO_0006995, MONDO_0004979 | |
| Disease | urate measurement | NOL4 ABCA1 SPP1 INTS7 MYO9A ADGRV1 CUBN AK5 SETBP1 CSPG4 TMF1 HFM1 QSOX2 EPAS1 | 1.06e-03 | 895 | 177 | 14 | EFO_0004531 |
| Disease | alkaline phosphatase measurement | DLG5 ACAP1 TRIM2 KIF16B LCP1 ADCY5 AZIN1 TRAFD1 RP1L1 ENTPD6 HFM1 SMS PRR14L SNX9 TCTN2 | 1.24e-03 | 1015 | 177 | 15 | EFO_0004533 |
| Disease | energy intake | 1.31e-03 | 134 | 177 | 5 | EFO_0003939 | |
| Disease | lymphocyte count | ACAP1 PCDHGC5 RNF19A RBBP8 SPTA1 ARHGEF18 GCSAML LCP1 ADCY5 ITPR2 PTPN4 PTPRC ENTPD1 KIRREL1 HFM1 ATL2 PPP2R3C IL7R DNPEP | 1.32e-03 | 1464 | 177 | 19 | EFO_0004587 |
| Disease | post-traumatic stress disorder symptom measurement | 1.52e-03 | 82 | 177 | 4 | EFO_0008535 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.54e-03 | 139 | 177 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | obesity (implicated_via_orthology) | 1.95e-03 | 215 | 177 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | renal cell carcinoma | 2.05e-03 | 42 | 177 | 3 | EFO_0000681 | |
| Disease | Malignant neoplasm of breast | AKAP6 NID2 ACAP1 SPP1 TRPC4 KIF16B DGKG CUBN PTHLH PTPRC BRCA2 GUCY2F SETBP1 DHX32 ZNF541 | 2.14e-03 | 1074 | 177 | 15 | C0006142 |
| Disease | spleen volume | 2.20e-03 | 43 | 177 | 3 | EFO_0600047 | |
| Disease | triglycerides in large LDL measurement | 2.20e-03 | 43 | 177 | 3 | EFO_0022319 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.50e-03 | 45 | 177 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | unipolar depression, bipolar disorder | 2.56e-03 | 156 | 177 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | C-reactive protein measurement | AKAP6 DOCK4 DCHS2 ABCA1 COQ5 LCP1 ATP8B2 ADCY5 CELSR2 AK5 RP1L1 ENTPD6 HFM1 SCAF11 KIAA2012 IL7R | 2.56e-03 | 1206 | 177 | 16 | EFO_0004458 |
| Disease | Benign tumor of pancreas | 2.67e-03 | 13 | 177 | 2 | C0347284 | |
| Disease | ceramide measurement | 3.03e-03 | 235 | 177 | 6 | EFO_0010222 | |
| Disease | cystatin C measurement | 3.07e-03 | 402 | 177 | 8 | EFO_0004617 | |
| Disease | trimethylamine-N-oxide measurement | 3.11e-03 | 14 | 177 | 2 | EFO_0010541 | |
| Disease | severe combined immunodeficiency (is_implicated_in) | 3.11e-03 | 14 | 177 | 2 | DOID:627 (is_implicated_in) | |
| Disease | body weights and measures, parental genotype effect measurement | 3.11e-03 | 14 | 177 | 2 | EFO_0004324, EFO_0005939 | |
| Disease | mean reticulocyte volume | MCFD2 SPTA1 URB2 ENPP4 LCP1 AZIN1 PTPRC AK5 PLK1 EPAS1 EPB41 PCM1 | 3.32e-03 | 799 | 177 | 12 | EFO_0010701 |
| Disease | P wave duration | 3.57e-03 | 15 | 177 | 2 | EFO_0005094 | |
| Disease | free cholesterol in large LDL measurement | 3.58e-03 | 51 | 177 | 3 | EFO_0022176 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 3.58e-03 | 51 | 177 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3.99e-03 | 53 | 177 | 3 | C1961099 | |
| Disease | phospholipids in medium HDL measurement | 4.43e-03 | 55 | 177 | 3 | EFO_0022295 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 4.55e-03 | 111 | 177 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | triglycerides in LDL measurement | 4.66e-03 | 56 | 177 | 3 | EFO_0022320 | |
| Disease | cholesterol to total lipids in large LDL percentage | 4.66e-03 | 56 | 177 | 3 | EFO_0022235 | |
| Disease | response to lithium ion | 4.66e-03 | 56 | 177 | 3 | GO_0010226 | |
| Disease | lipoprotein A measurement | 4.70e-03 | 112 | 177 | 4 | EFO_0006925 | |
| Disease | low density lipoprotein cholesterol measurement, lipid measurement | 5.00e-03 | 114 | 177 | 4 | EFO_0004529, EFO_0004611 | |
| Disease | Meckel syndrome type 1 | 5.14e-03 | 18 | 177 | 2 | C3714506 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 5.14e-03 | 18 | 177 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | urate measurement, spine bone mineral density | 5.14e-03 | 58 | 177 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | low density lipoprotein particle size measurement | 5.14e-03 | 58 | 177 | 3 | EFO_0008593 | |
| Disease | Amyotrophic Lateral Sclerosis | 5.14e-03 | 58 | 177 | 3 | C0002736 | |
| Disease | total lipids in medium HDL measurement | 5.14e-03 | 58 | 177 | 3 | EFO_0022310 | |
| Disease | cholesterol in medium HDL measurement | 5.39e-03 | 59 | 177 | 3 | EFO_0021903 | |
| Disease | non-melanoma skin carcinoma | 5.43e-03 | 265 | 177 | 6 | EFO_0009260 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 5.65e-03 | 118 | 177 | 4 | EFO_0010119 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 5.65e-03 | 60 | 177 | 3 | EFO_0022282 | |
| Disease | Pancreatic carcinoma | 5.72e-03 | 19 | 177 | 2 | C0235974 | |
| Disease | Omenn Syndrome | 5.72e-03 | 19 | 177 | 2 | C2700553 | |
| Disease | hemifacial microsomia | 5.72e-03 | 19 | 177 | 2 | MONDO_0015398 | |
| Disease | Hypermetropia, Myopia | 5.76e-03 | 189 | 177 | 5 | HP_0000540, HP_0000545 | |
| Disease | phospholipids in HDL measurement | 5.92e-03 | 61 | 177 | 3 | EFO_0022293 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLLQEEGHSDYINGN | 76 | Q99952 | |
| LSSYKEGLLDQQQGD | 251 | Q14146 | |
| YESSGTVNNDDSDLL | 321 | O95429 | |
| YNADSGLKAEANGDL | 396 | Q9UMD9 | |
| EDSDNSAIYVQGLND | 356 | Q01844 | |
| QLEYEEQAFQDLSGG | 711 | Q99814 | |
| TYEAAQTDDNSGDLD | 766 | P11171 | |
| SLDLGALQGSEYLQD | 21 | Q6ZSZ5 | |
| QTQGDLSAYEAELEA | 696 | Q7Z7A1 | |
| GEESYNLDSVAKNGL | 161 | Q96HD9 | |
| AQELYAAGENRLGTD | 361 | P50995 | |
| SEGDVLKVYDGNNNS | 1146 | Q7Z408 | |
| QEGDGSAYTVSEDEL | 1066 | P13611 | |
| DGDSGSEDLVYTIEQ | 1501 | Q6UVK1 | |
| LGEQNRTEYGKDSNT | 416 | Q99708 | |
| IEEKGSDGAASSYQL | 346 | Q14203 | |
| TLYDNEEVGSESAQG | 306 | Q9ULA0 | |
| TSGYDDKQERQSLGE | 411 | O14639 | |
| DDANYSVGLLDEGTN | 6 | O14977 | |
| YSDDDEINGVTQGDR | 416 | O60729 | |
| SDKDSGANGEIAYTI | 1021 | Q6V0I7 | |
| NGLIKYSISSGNEEG | 3121 | Q6V0I7 | |
| GNGTEEDAETFYDNS | 336 | O95477 | |
| GKDNNGNLIGSDEYE | 286 | Q8WXG9 | |
| SLGYDVENDRQGEAE | 796 | O43707 | |
| LGGTISYEAQDKTQD | 181 | P06127 | |
| EAAQGQAGDETYLDI | 701 | Q15027 | |
| DSDLSLEDDQSGSYA | 2721 | Q9HCU4 | |
| VAESAVNYSLGDEQG | 881 | O95622 | |
| DSDLQLYKEQGEGQG | 191 | Q01433 | |
| DLDYLAALDNDGNLS | 461 | Q7L7V1 | |
| YSDDDEINGVTQGDR | 386 | A4D256 | |
| ADATRDDGTQLADYQ | 996 | P98198 | |
| EDTDDAEGYLNSGNS | 176 | Q7Z5Q5 | |
| GQTYVGRDDASTEQD | 476 | Q96L93 | |
| GGQSDLGYNSLSKDE | 901 | Q7Z401 | |
| EDSVLQGYDINSQGE | 471 | Q9Y5P3 | |
| GKDSYETSQLDDQSA | 221 | P10451 | |
| ASDLDEGLNGDIIYS | 266 | Q9Y5H5 | |
| SGDGIDYSQQKRENI | 246 | Q96M98 | |
| NLLDTYSADQGDSSE | 566 | Q6ZRP7 | |
| ADAGYGEQELDANSA | 11 | Q9NVH2 | |
| EQDYFGLQLADDSTD | 66 | P29074 | |
| EKSSNYENGEIGESQ | 1131 | Q14571 | |
| QDDGGSDQNYDIVTI | 346 | Q96PE3 | |
| AEDLDLGENAQITYS | 476 | Q9Y5F3 | |
| DVAGQGYLRESDLEN | 181 | Q969Q6 | |
| ASDLDEGLNGDIIYS | 266 | Q9UN72 | |
| EGPNAEISYSIEDGN | 1281 | Q14517 | |
| DADAGVNGAVTYEIN | 281 | Q96JQ0 | |
| DDLDQGSGGQISYSL | 2196 | Q96JQ0 | |
| DGSAYIEQGNTKALA | 36 | Q9NPD3 | |
| KELYESNGSNRGEDA | 1151 | Q15058 | |
| SQSLLDSDDGNTYLD | 46 | P01614 | |
| DNYGDSEDLDLQATQ | 686 | Q14676 | |
| EKGDSNDDYDSAGLL | 196 | Q96GA3 | |
| GSNDSDRYSDNEEGK | 176 | P42166 | |
| DGEDYNFLQGASDQE | 601 | Q05BQ5 | |
| DYDGNNLLDGLELST | 81 | Q8NI22 | |
| YLEAEQQLAALEGGS | 41 | Q4ZG55 | |
| TGSDYEDQGDDQLNV | 346 | Q9Y6K8 | |
| NDVGQKFYLDTGDAS | 336 | P16233 | |
| AQGKDGEYEELLNSS | 346 | Q86W92 | |
| SGKNQELGAVSLDGY | 271 | Q5VW00 | |
| QALTNYGSGEDENED | 1791 | Q15154 | |
| VDTDGNGYISFNELN | 21 | P13796 | |
| VYRTDTLENGSNKGE | 276 | Q8IYA7 | |
| ATDPDEGTNGQLDYS | 266 | Q9Y5F6 | |
| SDDGINADLNYSIVG | 771 | O60245 | |
| LNESSQKLGDHGYDN | 326 | Q9Y6X5 | |
| SDSRDLDGSYDQLTG | 11 | Q9NS61 | |
| GQKDSGISLENGVYA | 726 | Q8TDM6 | |
| GTNAEDAGDDLLLSY | 366 | P52848 | |
| LKESGNALDYQEEAG | 716 | Q0VF49 | |
| AVDYFDGGKDQNSLS | 156 | Q6P1A2 | |
| LDGNSFYKIISNEEG | 366 | P27487 | |
| ASAAEAQGGEQAYLA | 1406 | Q96RT7 | |
| ESGYAQNGDLEDAEL | 21 | P16871 | |
| GSLEAQEYQLDKEGS | 51 | Q6PI73 | |
| GGDKETYNNIIRSGE | 3541 | P98088 | |
| SASELADSEGGEEYN | 461 | Q76FK4 | |
| SNTGEIKVNGELDYE | 296 | Q9Y5H7 | |
| YETNNQETFGALDLG | 201 | P49961 | |
| SAVDKDEGLNGQTEY | 1956 | Q6V1P9 | |
| LGGQALDDYVANTDN | 156 | Q96F15 | |
| SDKYEQDDLNLEGVG | 96 | A2PYH4 | |
| AEDLDVGSNGLQKYT | 156 | Q9Y5E5 | |
| GTYEVGLEDNIGSNT | 461 | Q14112 | |
| ASDLDEGLNGDIVYS | 266 | Q9UN74 | |
| STGDQAAKGNYGLLD | 246 | Q9NZ94 | |
| LGDDDAYLGNQRSKE | 141 | Q9BXP8 | |
| DDGGSSKYDILASED | 56 | O95400 | |
| KLYDGDSENANLAGT | 3221 | O60494 | |
| ALTEFNEGGSLKQYD | 31 | P49619 | |
| SLSSNDDGYENIDSL | 81 | Q5JQS6 | |
| DTDYQEGLRSLSQEG | 311 | Q8IUX4 | |
| INSGNGSTYEEETNK | 101 | Q8N4S0 | |
| DTLFGILDENSQKYG | 621 | Q8N1I0 | |
| LEFNDGAYNIKDSTG | 416 | Q16658 | |
| NKSASGYLTDENEVG | 1201 | P51587 | |
| GIYEDNEISNNALAG | 421 | Q86XK2 | |
| GVGNSYIEDNDDDSK | 141 | Q9UK97 | |
| GGDYLQIKNATEDAS | 411 | A2CJ06 | |
| IAEDISGNNGYVELS | 221 | Q9UBL6 | |
| ESGELNQYSAKSGEV | 166 | Q13347 | |
| TDSNGNGISEYVILD | 396 | P51841 | |
| YIAQVLQDSEVDGDG | 771 | Q5T3F8 | |
| TTSLGENYEDDDLVN | 36 | Q8NHH9 | |
| GKNIGAQSNDDSEYV | 206 | Q6ZWL3 | |
| IAKEYQNEEDSLGGS | 151 | Q5HYK3 | |
| GSADAGQYNLEITDA | 76 | Q96J84 | |
| GQYNLEITDAELSDD | 81 | Q96J84 | |
| SQSLLDSDDGNTYLD | 46 | A0A087WW87 | |
| IRAADTDGDGQVNYE | 126 | P27482 | |
| SDINDINSVDGNYIG | 516 | Q05BV3 | |
| DGEQLENNYLVSATG | 106 | Q6PCB8 | |
| EGKYTDLNSNDVTGL | 41 | Q15007 | |
| GEENGDNTISTGLLY | 21 | Q99590 | |
| AGLLSDKSENGEAYQ | 146 | Q8N1S5 | |
| ENYQKGERGEDSSEE | 171 | P05060 | |
| EDSYNGRGQGELSSE | 306 | Q8NCQ7 | |
| LDFGEEKNYSDGSET | 311 | Q9H4L5 | |
| YTSQERELDGKETNG | 851 | Q5THK1 | |
| AVAEGNRTEAGSQDY | 121 | Q8ND04 | |
| GTIDGTKDENSDYTL | 91 | P61328 | |
| DLYDDSIGDSATQQS | 116 | Q8N2Y8 | |
| ESEGGYTTANAESDN | 171 | Q96TC7 | |
| SSGYQGETDLNDAIT | 451 | Q9Y5X1 | |
| LDLQSYDGDAQGKEE | 71 | P52788 | |
| ASSQGDGLYKELADV | 736 | Q68CJ6 | |
| AGTVDSSQGQGYLEE | 276 | Q9NQ40 | |
| DENEDDVYGNSSGRK | 351 | Q8TEQ0 | |
| QGDLSSGYLDDTKQE | 426 | O14545 | |
| GLSAYADDVEKSAQG | 141 | O75354 | |
| YISSGNSDNGKEDLE | 341 | Q9NSI8 | |
| QGDLSGEEDQSALYA | 211 | Q9ULN7 | |
| NEDYDGTGKLGNLTA | 486 | Q86UG4 | |
| GKNSGLYDSSGEEEE | 226 | Q5C9Z4 | |
| EIDAIGTKRYDSNSG | 286 | P62191 | |
| YDSGKNESVDRGAED | 361 | O94818 | |
| ATAESQDYGQDLEGV | 3126 | Q9NRC6 | |
| VGSNGLLDFDSEYQE | 956 | Q13023 | |
| GESYDQAIRNDETGL | 1181 | Q7KZ85 | |
| YGLLQSSDNSEDEEE | 1126 | Q15468 | |
| EINSDDELSGKGYAL | 341 | P82094 | |
| TEKSYGIDENGRDEN | 406 | Q96T68 | |
| DGSAYIIEDSKESGQ | 136 | Q86UP3 | |
| AELENSGLALYDGKD | 326 | Q6NZY4 | |
| SSDDYGQLGVQALEN | 216 | Q7RTX1 | |
| YLTEGSNGEVDISNG | 561 | Q9Y5T5 | |
| GEGEESELQNTAYSN | 1131 | O75970 | |
| ALLQATGAQEDEYGQ | 291 | P20142 | |
| ADVQKERYSLSGESG | 566 | Q9NV58 | |
| ASEGYDLQEDQALGS | 2366 | Q8IWN7 | |
| LYDAANEGSQLATGI | 91 | P38935 | |
| ANTVEADGSNDEGYE | 161 | Q08AE8 | |
| ELEGDSENQGSIYLS | 591 | Q96IC2 | |
| EEEGGIANYNTSSKE | 46 | Q92752 | |
| EYDSNSDQSGSQEKL | 696 | O94885 | |
| TSEDYGKGLAEVQNR | 711 | P02549 | |
| IVDNTNYGADEEAAG | 921 | P02549 | |
| GSDDEGRYLTQETNK | 96 | P12272 | |
| YQGRDDEASNLVGEE | 201 | Q8N392 | |
| TSLETGQGYEDEQDG | 181 | Q8NAM6 | |
| SIGNKGEDQSIEDQY | 51 | Q15973 | |
| YSRKNQDSEVDGGIT | 696 | Q9ULQ1 | |
| RGNYEELENSGDTTV | 21 | Q6P9G4 | |
| VADGEILDNKNGTYE | 376 | Q9C040 | |
| NTYTGSGDEDALSEE | 881 | Q5VYS8 | |
| TAEDNGILLYNGDND | 1196 | O75093 | |
| EGKREGYSADSAQEA | 366 | Q9Y6X0 | |
| YNRVELSEINGDAGS | 691 | P08575 | |
| ADEDLLSQYENGSST | 486 | Q92547 | |
| SGNKDYGLLQLEEGA | 251 | Q5SRH9 | |
| KFLSYNSGNEEELSG | 421 | Q96GX1 | |
| QNYGETVQGTDSKDL | 81 | Q9UL59 | |
| GSENSLLDEDDYFLN | 61 | Q5VZL5 | |
| YRDDNSLIEEQSGND | 271 | Q9UBN4 | |
| FNSNYIDIESNSEGG | 701 | Q7Z3T8 | |
| EYADSESQASLQDLG | 91 | Q9H0D2 | |
| EGSYGTVSEIQNLEE | 281 | Q15916 | |
| NGTTSETEDEEIYGN | 641 | Q96T25 | |
| GPTNEEDYKNEGQLS | 11 | Q9UJN7 | |
| NDGDSLQYIERDGTE | 446 | P53350 | |
| QGLDTDAESVNLDDY | 2111 | B2RTY4 | |
| EDEGTYTFQLQDGKA | 1311 | P52179 | |
| SEEDKGSYTAQLQDG | 1071 | Q5VTT5 |